Psychosis and vulnerability to ECT-induced seizures.
Medical records of patients with major depressive disorders who had received electroconvulsive therapy (ECT) for the first time were studied to test the hypothesis that psychotic patients are more vulnerable to seizures than nonpsychotic patients. This hypothesis was based on studies suggesting a putative purinergic deficiency in psychosis. Results showed that the duration of ECT-induced seizures as a measure of seizure vulnerability was significantly longer in psychotic than in nonpsychotic depressive patients. The association applied for the first ECT as well as for the course of eight ECTs. These findings were still present when covariates such as age, electrical energy applied, dosage of methohexital and succinylcholine, and psychotropic medications such as neuroleptics, benzodiazepines, and tricyclics were included in the statistical analysis. The results are discussed in the context of the role of neurotransmitters such as glutamate, gamma-aminobutyric acid, adenosine, and dopamine on seizure vulnerability and psychosis.
Waziri
R
R
Psychiatry Research-MEB, University of Iowa, Iowa City 52242-1000, USA.
Baruah
S
S
Arndt
S
S
Baumert
K
K
Cooney
J
J
Christensen
L
L
D000328:Adult; D000368:Aged; D002540:Cerebral Cortex / Q000503:physiopathology; D003866:Depressive Disorder / Q000503:physiopathology* / Q000523:psychology / Q000628:therapy; D004565:Electroconvulsive Therapy; D004569:Electroencephalography; D005260:Female; D012696:Glycine Hydroxymethyltransferase / Q000172:deficiency / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000502:physiology; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000503:physiopathology* / Q000523:psychology / Q000628:therapy; D011687:Purines / Q000378:metabolism; D012640:Seizures / Q000503:physiopathology*
D018377:Neurotransmitter Agents; D011687:Purines; D012696:Glycine Hydroxymethyltransferase